Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tecogen (TGEN) EBT (2016 - 2025)

Tecogen (TGEN) has disclosed EBT for 14 consecutive years, with -$2.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT fell 136.19% year-over-year to -$2.1 million, compared with a TTM value of -$5.4 million through Sep 2025, down 2.09%, and an annual FY2024 reading of -$4.7 million, down 3.57% over the prior year.
  • EBT was -$2.1 million for Q3 2025 at Tecogen, down from -$1.5 million in the prior quarter.
  • Across five years, EBT topped out at $1.8 million in Q1 2021 and bottomed at -$2.1 million in Q3 2025.
  • Average EBT over 5 years is -$631306.2, with a median of -$831335.0 recorded in 2022.
  • The sharpest move saw EBT soared 803.54% in 2021, then tumbled 2262.31% in 2022.
  • Year by year, EBT stood at $66124.0 in 2021, then crashed by 2262.31% to -$1.4 million in 2022, then decreased by 27.88% to -$1.8 million in 2023, then skyrocketed by 35.5% to -$1.2 million in 2024, then tumbled by 79.44% to -$2.1 million in 2025.
  • Business Quant data shows EBT for TGEN at -$2.1 million in Q3 2025, -$1.5 million in Q2 2025, and -$659564.0 in Q1 2025.